title: Dolutegravir: a new integrase strand transfer inhibitor for the treatment of HIV - an alternative viewpoint.
authors.affiliation: Michael E. DeBakey VA Medical Center, Baylor College of Medicine, Houston, Texas.
authors.forename: Michael A
authors.initials: MA
authors.lastname: Gillette
authors.forename: Bhavik M
authors.initials: BM
authors.lastname: Shah
authors.forename: Jason J
authors.initials: JJ
authors.lastname: Schafer
authors.forename: Joseph A
authors.initials: JA
authors.lastname: DeSimone
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000493:pharmacokinetics; D004347:Drug Interactions; D015658:HIV Infections / Q000188:drug therapy; D019428:HIV Integrase Inhibitors / Q000009:adverse effects / Q000494:pharmacology*; D006575:Heterocyclic Compounds, 3-Ring / Q000009:adverse effects / Q000494:pharmacology*; D006801:Humans; D010078:Oxazines; D010627:Phenethylamines / Q000009:adverse effects* / Q000493:pharmacokinetics; D010879:Piperazines; D011728:Pyridones; D013449:Sulfonamides / Q000009:adverse effects* / Q000493:pharmacokinetics; D000099226:Dolutegravir
chemical_list: D000889:Anti-Arrhythmia Agents; D019428:HIV Integrase Inhibitors; D006575:Heterocyclic Compounds, 3-Ring; D010078:Oxazines; D010627:Phenethylamines; D010879:Piperazines; D011728:Pyridones; D013449:Sulfonamides; D000099226:Dolutegravir; C063533:dofetilide
keywords: atrial fibrillation; dofetilide; dolutegravir; drug interactions